Evidence map›Paper›PMID 23303388›Full record

ArticleJAMA internal medicine2013

Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and control.

Jeanne S Mandelblatt, Anna N A Tosteson, Nicolien T van Ravesteyn

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA internal medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jeanne S MandelblattGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA. mandelbj@georgetown.edu
Anna N A Tosteson
Nicolien T van Ravesteyn

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KARLA M KERLIKOWSKE, Diana L Miglioretti · 2011 to 2026
$52.9M
Comparative Modeling: Informing Breast Cancer Control Practice & PolicyU01CA152958 · NCI · GEORGETOWN UNIVERSITY · PI BERRY, DONALD A, DE KONING, HARRY J · 2010 to 2015
$7.6M
Promoting personalized decisions for breast cancer screening for women AND theirU54CA163307 · NCI · DARTMOUTH COLLEGE · PI HAAS, JENNIFER S, ONEGA, TRACY · 2011 to 2017
$6.1M
OUTCOMES ACROSS THE SPECTRUM OF BREAST CANCER CAREU01CA088283 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2000 to 2010
$2.6M
Comparative effectiveness of breast imaging strategies in community practiceRC2CA148577 · NCI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI BUIST, DIANA SM, GELLER, BERTA M · 2009 to 2009
$2.0M
Cancer Control at the Intersection of Aging ResearchK05CA096940 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2002 to 2011
$1.5M
NCI NIH HHS K05 CA096940NCI NIH HHS K05CA96940NCI NIH HHS P01 CA154292NCI NIH HHS P01CA154292NCI NIH HHS RC2 CA148577NCI NIH HHS RC2CA148577NCI NIH HHS U01 CA088283NCI NIH HHS U01CA088283NCI NIH HHS U01 CA152958NCI NIH HHS U01CA152958NCI NIH HHS U54 CA163307NCI NIH HHS U54CA163307
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsFemaleHumansMass ScreeningMedicare

Identifiers

PMID23303388
PMCPMC4071606

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.